Myocardial Ischemia Clinical Research Trials

Birmingham : Cardiology PC

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Birmingham : University of Alabama at Birmingham

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Birmingham : Cardiology, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Birmingham : University of Alabama at Birmingham

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Birmingham : University Hospital - Univ. of Alabama at Birmingham (UAB)

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Birmingham : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Huntsville : Huntsville Hospital - The Heart Center, PC Updated

PROMUS Element Plus US Post-Approval Study

Huntsville : Heart Center Research, LLC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Huntsville : Heart Center Research, LLC

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Huntsville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mobile : Cardiology Associates of Mobile, Inc.

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Anchorage : Alaska Heart Institute

PRE-DETERMINE Cohort Study

Anchorage : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Little Rock : Arkansas Heart Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Gilbert : Mercy Gilbert Medical Center

An Observational Study of Cholesterol in Coronary Arteries

Gilbert : Mercy Gilbert Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Gilbert : Arizona Sun Family Medicine

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Glendale : Phoenix Heart, PLLC

PRE-DETERMINE Cohort Study

Meza : Banner Heart Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Phoenix : Arizona Heart Institute Ltd.

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Phoenix : Mayo Clinic Hospital, Cardiac Cath Lab

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Phoenix : Cardiovascular Consultants

PRE-DETERMINE Cohort Study

Scottsdale : Scottsdale Medical Imaging, Ltd.

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Scottsdale : Scottsdale Healthcare

An Observational Study of Cholesterol in Coronary Arteries

Scottsdale : Scottsdale Healthcare Shea

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Scottsdale : Scottsdale Healthcare Osborn Campus

Evaluation of Patients in Chest Pain in the Emergency Room

Scottsdale : Scottsdale Healthcare Shea Campus

Evaluation of Patients in Chest Pain in the Emergency Room

Scottsdale : Scottsdale Healthcare

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tempe : Fiel Family Medicine

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Jonesboro : NEA Baptist Memorial Hospital Updated

PROMUS Element Plus US Post-Approval Study

Jonesboro : St. Bernard's Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Little Rock : Arkansas Heart Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Beverly Hills : West Side Medical Associates of Los Angeles

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Concord : John Muir Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Concord : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Fullerton : St. Jude Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Glendale : Glendale Memorial Hospital and Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

La Jolla : Scripps Clinic

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

La Jolla : University of California San Diego

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

La Jolla : Scripps Memorial Hospital La Jolla

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Lajolla : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Loma Linda : Loma Linda University Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Lomita : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Los Angeles : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Los Angeles : Cedars-Sinai Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Los Angeles : VA West Los Angeles Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Los Angeles : UCLA

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Los Angeles : USC PET Imaging Science Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Los Angeles : University of California, Los Angeles Medical Center

An Observational Study of Cholesterol in Coronary Arteries

Los Angeles : David Geffen School of Medicine at UCLA

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Los Angeles : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Los Angeles : University of Southern California

Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)

Madera : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mission Viejo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Mission Viejo : Mission Internal Medical Group

Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors

Moreno Valley : Spectrum Clinical Research Institute, Inc

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Northridge : Cardiac Rhythm Specialists, Inc.

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Oakland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Orange : University of California Irvine Medical Center

An Observational Study of Cholesterol in Coronary Arteries

Oxnard : St. John's Regional Medical Center, Catholic Healthcare West

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Palo Alto : Veterans Affairs Palo Alto Health Care System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Pasadena : Novartis Investigative Site

Efficacy of LCQ908 on Cardiovascular Risk

Pleasant Hill : Cardiovascular Consultants Medical Group

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Poway : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sacramento : Northern California PET Imaging Center-Palo Alto

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Sacramento : Sutter Heart and Vascular Institute

LifeVest Post-CABG Registry

Sacramento : Mercy Heart and Vascular Institue

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Sacramento : Mercy General Hospital Updated

PROMUS Element Plus US Post-Approval Study

Sacramento : Sutter Memorial Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Sacramento : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Diego : VA San Diego Healthcare System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

San Diego : University of California, San Diego

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

San Diego : Veterans Affairs San Diego Healthcare System

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

San Diego : Alvarado Hospital Medical Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

San Diego : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Francisco : UCSF Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

San Francisco : San Francisco Veterans Affairs Medical Center

An Observational Study of Cholesterol in Coronary Arteries

San Francisco : San Francisco Veterans Affairs Medical Center

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

San Francisco : San Francisco Veterans Affairs Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

San Ramon : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Santa Ana : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Santa Clara : Abbott Vascular

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System

Santa Clara : Abbott Vascular

EXCEL Clinical Trial

Santa Clara : Abbott Vascular

EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions

Spring Valley : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Stanford : Stanford University, James Clark Center E-120

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Walnut Creek : John Muir Medical Center Concord Campus

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Westlake Village : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Aurora :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Colorada Springs : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Colorado Springs : Pikes Peak Cardiology

PRE-DETERMINE Cohort Study

Colorado Springs : Colorado Cardiac Alliance

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Denver : Colorado Heart and Vascular

PRE-DETERMINE Cohort Study

Denver : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Golden : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Littleton : South Denver Cardiology Associates, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Thornton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bridgeport : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hartford : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New Haven : Yale University

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

New Haven : Yale New Haven Hospital

Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion

New Haven : Yale University School of Medicine

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Newark : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Newark : Alfieri Cardiology

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Newark : Christiana Care Health System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Newark : Christiana Hospital Updated

PROMUS Element Plus US Post-Approval Study

Newark : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wilmington : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Washington : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Washington : Washington Hospital Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Washington : Washington Hospital Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Daytona Beach : Cardiology Research Associates

Stem Cell Study for Patients with Refractory Angina and Chronic Myocardial Ischemia

Atlantis : Zasa Clinical Research

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Atlantis : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Aventura : Elite Research and Clinical Trials

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Boynton Beach : Independent Imaging, LLC

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Boynton Beach : Bethesda Memorial Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Brandon : Bay Area Cardiology Associates, P.A.

PRE-DETERMINE Cohort Study

Brandon : Brandon Regional Hospital Updated

PROMUS Element Plus US Post-Approval Study

Clearwater : Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Clearwater : Morton Plant Hospital - Heart and Vascular Institute of Florida Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Cooper City :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Daytona Beach : Cardiology Research Associates

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Daytona Beach : Cardiology Research Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Fort Lauderdale : Broward General Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Fort Myers : Florida Heart Associates

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Gainesville : University of Florida, Gainesville

An Observational Study of Cholesterol in Coronary Arteries

Gainesville : University of Florida, Division of Cardiovascular Medicine

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Gainesville : University of Florida - Gainsville

PRE-DETERMINE Cohort Study

Gainesville : North Florida Regional Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Gainesville : University of Florida

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Gainesville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hialeah : Future Care Solution, LLC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Hialeah : Michigan Heart, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Hollywood : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Hollywood : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Hollywood : Memorial Regional Hospital Updated

PROMUS Element Plus US Post-Approval Study

Jacksonville : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Jacksonville : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Jacksonville : St. Luke's Cardiology Associates

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Jacksonville : Mayo Clinic - Jacksonville

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Jacksonville : University of Florida, Shands Jacksonville Cardiovascular Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Jacksonville : Mayo Clinic Research Unit

Exercise Stress Testing on Peripheral Gene Expression Using CORUS™ CAD Diagnostic Test

Jacksonville : University of Florida

Impact of Ticagrelor Re-load on Pharmacodynamic Profiles

Jacksonville : Shands Jacksonville Medical Center

PRE-DETERMINE Cohort Study

Jacksonville : Cardiology Consultants of Northwest Florida

PRE-DETERMINE Cohort Study

Jacksonville : University of Florida - Jacksonville

PRE-DETERMINE Cohort Study

Jacksonville : East Coast Institute for Research

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jacksonville : Jacksonville Heart Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jacksonville : Mayo Clinic Jacksonville

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jacksonville : University of Florida Health Sciences Center-Jacksonville

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jacksonville : University of Florida

Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab

Jacksonville : First Coast Cardiovascular Institute

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Jacksonville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jacksonville Beach : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lake Mary : The Cardiovascular Center, PA

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Lakeland : Watson Clinic Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Melbourne : Melbourne Cardiac Research Institute

PRE-DETERMINE Cohort Study

Miami : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Miami : University of Miami School of Medicine

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Miami : Reliable Clinical Research

PRE-DETERMINE Cohort Study

Miami : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Miami Beach : Mount Sinai Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Miami Beach : Mount Sinai Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Ocala : Munroe Regional Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Ocala : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Orlando : Florida Hospital/Cardiovascular Institute (Florida Heart Group)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Orlando : Florida Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Orlando : Florida Hospital Cardiovascular Research Institute

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Orlando : Florida Hospital

PRE-DETERMINE Cohort Study

Orlando : Orlando Regional Medical Center

PRE-DETERMINE Cohort Study

Orlando : Orlando Regional Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Orlando : Florida Hospital Orlando

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Palm Beach Gardens : Palm Beach Gardens Research Center

PRE-DETERMINE Cohort Study

Panama City : Bay Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Panama City : Cardiovascular Institute of Northwest Florida

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Pembroke Pines : South Florida Research Solutions

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Ponte Verda : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sarasota : Velella Research

PRE-DETERMINE Cohort Study

Stuart : Martin Memorial Health Systems - Martin Memorial Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Tallahassee : Tallahassee Research Institute, Inc.

PRE-DETERMINE Cohort Study

Tallahassee : Tallahassee Research Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tallahassee : Tallahassee Research Institute, Inc.

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Tampa : Memorial Hospital of Tampa

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Tampa : Pepin Heart Hospital

An Observational Study of Cholesterol in Coronary Arteries

Tampa : Florida Hospital Pepin Heart Institute/Dr. Kiran C. Patel Research Institute

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Tampa : Pepin Heart Hospital and Dr. Kiran C. Patel Research Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

West Palm Beach : Cardiology Associates of Palm Beach - West Palm Beach

PRE-DETERMINE Cohort Study

Winter Park :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Atlanta : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Atlanta : Piedmont Hospital

An Observational Study of Cholesterol in Coronary Arteries

Atlanta : St. Joseph Hospital of Atlanta

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Atlanta : Saint Joseph's Health System, Inc.

LifeVest Post-CABG Registry

Atlanta : Emory University Hospital Midtown

Management of New-Onset Postoperative Atrial Fibrillation

Atlanta : Piedmont Hospital Updated

PROMUS Element Plus US Post-Approval Study

Atlanta : Emory University Hospital

RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery

Atlanta : Emory University Hospital

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

Augusta : Georgia Health Sciences Univ/Med College of GA

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Conyers : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Covington : Georgia Heart Specialist

PRE-DETERMINE Cohort Study

Cumming : Atlanta Heart Specialist, LLC

Ranolazine, Ethnicity and the Metabolic Syndrome

Gainesville : Northeast Georgia Heart Center, P.C.

PRE-DETERMINE Cohort Study

Gainesville : Northeast Georgia Heart Center, PC

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Macon : Coliseum Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Savannah : South Coast Imaging Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Tucker : Atlanta Heart Specialists, LLC

Ranolazine, Ethnicity and the Metabolic Syndrome

Woodstock : Town Lake Internal Medicine

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Honolulu : Kaiser Foundation Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Aurora : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chicago : Northwestern University

Comprehensive Evaluation of Ischemic Heart Disease Using MRI

Chicago : Northwestern Memorial Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Chicago : Rush University Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Chicago : Northwestern University

Half-Dose Radiopharmaceutical in Wide Beam Reconstruction

Chicago : Northwestern University Feinberg School of Medicine

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Chicago : Advocate Medical Group - Heart and Vascular of IL

PRE-DETERMINE Cohort Study

Chicago : University of Chicago

PRE-DETERMINE Cohort Study

Chicago : University of Chicago Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Chicago : Northwestern Memorial Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Chicago : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Evanston : Evanston Northwestern Healthcare - Evanston Hospital

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

Jerseyville : Gateway Cardiology, PC

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Jerseyville : Gateway Cardiology, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Melrose Park : Consultants in Cardiovascular Medicine

PRE-DETERMINE Cohort Study

Melrose Park : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Quincy : Blessing Hospital Updated

PROMUS Element Plus US Post-Approval Study

Anderson : Community Heart and Vascular

PRE-DETERMINE Cohort Study

Avon : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Carmel : Clarian North Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Fort Wayne : Northern Indiana Research Alliance

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Franklin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Greenfield : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Indianapolis :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Indianapolis : Franciscan St. Francis Hospital Updated

PROMUS Element Plus US Post-Approval Study

Indianapolis : Indiana Heart Hospital Updated

PROMUS Element Plus US Post-Approval Study

Indianapolis : The Indiana Heart Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Indianapolis : Indiana Heart Physicians, Inc.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Indianapolis : St. Vincent's Medical Group, Inc.

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Indianapolis : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Valparaiso : Northwest Indiana Cardiovascular Physicians

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Valparaiso : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Des Moines : Mercy Hospital Medical Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Iowa City : University of Iowa, Dept. of Cardiology

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Iowa City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

West De Moines : Iowa Heart Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

West Des Moines : Iowa Heart Medical Center

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

West Des Moines : Iowa Heart Center

PRE-DETERMINE Cohort Study

West Des Moines : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kansas City : Cardiovascular Imaging Technologies

A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD)

Kansas City :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kansas City : The University of Kansas

PRE-DETERMINE Cohort Study

Kansas City : Mid-America Cardiology Associates, PC

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Overland Park : Midwest Cardiology Associates

GLOBAL Clinical Study

Shawnee Mission : Shawnee Mission Hospital

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

Ashland : Kentucky Heart Institute / King's Daughter

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Ashland : Kings Daughters Medical Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Crestview Hills : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lexington : Central Baptist Hospital

PRE-DETERMINE Cohort Study

Lexington : St. Joseph Hospital Updated

PROMUS Element Plus US Post-Approval Study

Lexington : Saint Joseph Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Lexington : Central Baptist Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Louisville : Norton Cardiovascular Associates

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Louisville : University of Louisville, Department of Anesthesiology and Perioperative Medicine

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Louisville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Houma : Cardiovascular Institute of the South Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Houma : Leonard J. Chabert Medical Center

PRE-DETERMINE Cohort Study

Lafayette : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Maringouin : Maringouin Medical Center

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Minden : Clinical Trials of America, Inc.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

New Iberia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New Orleans : LSU Health Sciences Center Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

New Orleans : Ochsner Clinic

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

New Orleans : Ochsner Medical Center

Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)

New Orleans : Interim LSU Public Hospital

PRE-DETERMINE Cohort Study

New Orleans : Ochsner Clinic Foundation

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

New Orleans : Ochsner Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Shreveport : Biomedical Research Foundation of Northwest Louisiana

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Shreveport : Cardiovascular Research, LLC Updated

PROMUS Element Plus US Post-Approval Study

Shreveport : Clinical Trials of America, Inc.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Simmesport : KD Health and Wellness Center

A Registry to Evaluate Patterns of Care Associated With the Use of Corus® CAD in Real World Clinical Care Settings

Slidell : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Zachary : The Bonin Clinic

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Auburn : Maine Research Associates

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Auburn : Maine Research Associates

PRE-DETERMINE Cohort Study

Auburn : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bangor : Eastern Maine Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Bangor : Northeast Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bangor : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lewiston : Maine Research Associates - Lewiston

PRE-DETERMINE Cohort Study

Scarborough : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Baltimore : Johns Hopkins University

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Baltimore : Sinai Center for Thrombosis Research

Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis

Baltimore : University of Maryland Medical Center

PRE-DETERMINE Cohort Study

Baltimore : Union Memorial Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Baltimore : MedStar Research Institute

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Baltimore : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oxon Hill : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Takoma Park : Washington Adventist Hospital

An Observational Study of Cholesterol in Coronary Arteries

Towson : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Towson : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Ayer : Primary Care Cardiology Research

PRE-DETERMINE Cohort Study

Boston : Boston University Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Boston : Mass General Hospital (MGH)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Boston :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Boston : Massachusetts General Hospital

An Observational Study of Cholesterol in Coronary Arteries

Boston : Beth Israel Deaconess Medical Center

An Observational Study of Cholesterol in Coronary Arteries

Boston : Brigham and Women's Hospital

PRE-DETERMINE Cohort Study

Boston : Saint Elizabeth's Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Boston : Tufts Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Boston : Massachusetts General Hospital

Subclinical Atherosclerosis in HIV-infected Patients

Boston : Massachusetts General Hospital

The Massachusetts General Hospital Optical Coherence Tomography Registry

Boston : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Burlington : Lahey Clinic

An Observational Study of Cholesterol in Coronary Arteries

Fall River : NECCR Internal Medicine and Cardiology Associates, LLC

PRE-DETERMINE Cohort Study

Hyannis : Cape Cod Hospital Updated

PROMUS Element Plus US Post-Approval Study

Hyannis : Cape Cod Research Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Natick : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

North Dartmouth : Hawthorn Medical Associates

PRE-DETERMINE Cohort Study

Springfield : Baystate Cardiology

PRE-DETERMINE Cohort Study

Worcester : University of Massachusettts Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Ann Arbor : University of Michigan Health System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Ann Arbor : St. Joseph Mercy-Michigan Heart Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Ann Arbor :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ann Arbor : University of Michigan Medical School

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Ann Arbor : University of Michigan Medical Center

PRE-DETERMINE Cohort Study

Cadillac : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dearborn : Oakwood Hospital & Medical Center

PRE-DETERMINE Cohort Study

Dearborn : Oakwood Hospital and Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Detroit : Henry Ford Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Detroit : Wayne State University - Harper University Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Detroit : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Grand Blanc : Genesys Regional Medical Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Grand Rapids : St. Mary's Healthcare (Trinity Health)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Grand Rapids : Spectrum Health Hospitals

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Grandville :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Lansing : Thoracic Cardiovascular Healthcare Foundation

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Mount Clemens : McLaren Macomb

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Mt. Clemens : McLaren Medical Center - Macomb

PRE-DETERMINE Cohort Study

Petoskey : Northern Michigan Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Petoskey : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rochester Hills : Crittenton Shelton Heart Center:

An Observational Study of Cholesterol in Coronary Arteries

Royal Oak : William Beaumont Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Royal Oak : William Beaumont Hospital

An Observational Study of Cholesterol in Coronary Arteries

Royal Oak : William Beaumont Hospital

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Royal Oak : William Beaumont Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Saginaw : Michigan Cardiovascular Institute

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

St. Joseph : Lakeland Hospitals at St. Joseph Updated

PROMUS Element Plus US Post-Approval Study

Ypsilanti : Michigan Heart

PRE-DETERMINE Cohort Study

Coon Rapids : Mercy Hospital Updated

PROMUS Element Plus US Post-Approval Study

Duluth : Essentia Health

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Duluth : St Mary's Duluth Clinic

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Minneapolis : Minneapolis Heart Institute at Abbott Northwestern Hospital

Alternative in Beta Blocker Intolerance: The ABBI Trial

Minneapolis : Minneapolis Heart Institute Foundation

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Minneapolis : Minneapolis Heart Institute

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Minneapolis : Minneapolis VA Medical Center

PRE-DETERMINE Cohort Study

Minneapolis : North Memorial Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Minneapolis : Minneapolis Heart Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Minneapolis : Minneapolis Heart Institute Foundation

Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia

Minneapolis : Abbott Northwestern Hospital

VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study

Rochester :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Rochester : Mayo Clinic

An Observational Study of Cholesterol in Coronary Arteries

Rochester : Mayo Clinic Updated

Assessment of Coronary Plaque Composition Using Optical Coherence Tomography

Rochester : Mayo Clinic

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

Rochester : Mayo Clinic

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Rochester : Mayo Clinic

Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

Rochester : Mayo Clinic

Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography

Rochester : Mayo Clinic

Regadenoson Real Time Perfusion Imaging Trial-Optison

Saint Cloud : Saint Cloud Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

St. Cloud : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St. Paul : United Hospital - St. Paul Heart Clinic Updated

PROMUS Element Plus US Post-Approval Study

Hattiesburg : Hattiesburg Clinic

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Hattiesburg : Forest County General Hospital Updated

PROMUS Element Plus US Post-Approval Study

Jackson : Jackson Heart Clinic

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Tupelo : Cardiology Associates of North Mississippi

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Columbia : Missouri Cardiovascular Specialists, LLP

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Columbia : University of Missouri Health Care

PRE-DETERMINE Cohort Study

Kansas City : Cardiovascular Imaging Technologies (CVIT)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Kansas City : Saint Luke's Mid America Heart and Vascular Institute

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

Kansas City : Saint Luke's Cardiovascular Consultants

Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging

Saint Louis : Saint Louis University School of Medicine

Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol

Saint Louis : Gateway Cardiology, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Springfield : Cox Medical Centers Updated

PROMUS Element Plus US Post-Approval Study

Springfield : St. John's Regional Health Center (Springfield) Updated

PROMUS Element Plus US Post-Approval Study

Springfield : Saint John's Regional Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Springfield : Cardiovascular Specialists of St. John's

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

St Louis : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St. Louis : Saint Louis University School of Medicine

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

St. Louis : Washington University School of Medicine

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

St. Louis :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

St. Louis : Saint Louis University Hospital

An Observational Study of Cholesterol in Coronary Arteries

St. Louis : Center for Clinical Imaging Research (CCIR) at Washington University School of Medicine

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

St. Louis : Missouri Baptist Medical Center

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

St. Louis : St. Louis University

Regadenoson to Achieve Maximal Hyperemia for Fractional Flow Reserve in the Catheterization Lab

St. Louis : Mercy Hospital St. Louis

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Kalispell : Glacier View Cardiology

PRE-DETERMINE Cohort Study

Grand Island : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Omaha : The Cardiac Center of Creighton University

PRE-DETERMINE Cohort Study

Omaha : University of Nebraska Medical Center

Regadenoson Real Time Perfusion Imaging Trial-Optison

Henderson : Cardiovascular Consultants of Nevada

Safety of Amiodarone and Ranolazine Together in Patients With Angina

Las Vegas : Las Vegas Radiology

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Las Vegas : Cardiovascular Consultants of Nevada

Safety of Amiodarone and Ranolazine Together in Patients With Angina

Las Vegas : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lebanon : Dartmouth Hitchcock Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bridgewater : Advanced Heartcare, LLC

PRE-DETERMINE Cohort Study

Browns Mills : Deborah Heart and Lung Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Browns Mills : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Camden : Cooper University Hospital

Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device

Cherry Hill : Associated Cardiovascular Consultants

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Elizabeth : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Englewood : Englewood Hospital & Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Hackensack : Hackensack University Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Haddon Heights : Cardiovascular Associates of the Delaware Valley

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Haddon Heights : Our Lady of Lourdes Medical Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Linden : Research Site

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Newark : Newark Beth Israel Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Paterson : St. Joseph Regional Medical Center

PRE-DETERMINE Cohort Study

Summit :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Teaneck : Holy Name Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Wayne : Wayne Cardiology

PRE-DETERMINE Cohort Study

West Orange : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Albuquerque : New Mexico VA Healthcare Systems

PRE-DETERMINE Cohort Study

Albuquerque : New Mexico Heart Institute

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Albuquerque : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Albany : Albany Associates Cardiology

PRE-DETERMINE Cohort Study

Albany : Albany Associates in Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bronx : Montefiore Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Brooklyn : East-West Research Inc.

PRE-DETERMINE Cohort Study

Brooklyn : New York Methodist Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Buffalo : Buffalo General Hospital/Kaleida Health

PRE-DETERMINE Cohort Study

Buffalo : Buffalo Heart Group

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Buffalo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jamaica : Jamaica Hospital Medical Center

PRE-DETERMINE Cohort Study

Kingston : Mid-Valley Cardiology

PRE-DETERMINE Cohort Study

Liverpool : SJH Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Manhasset : North Shore University Hospital, NY

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Mineola : Winthrop-University Hospital

PRE-DETERMINE Cohort Study

N. Massapequa :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

New Hyde Park : Long Island Jewish Medical Center

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

New York : Columbia University Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

New York : Mount Sinai Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

New York : Columbia Universtiy Medical Center

An Observational Study of Cholesterol in Coronary Arteries

New York : Mount Sinai School of Medicine

An Observational Study of Cholesterol in Coronary Arteries

New York : Mount Sinai School of Medicine Hospital

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

New York : New York Presbyterian Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

New York : Novartis Investigative Site

Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease

New York : Columbia University Health Center

PRE-DETERMINE Cohort Study

New York : Gotham Cardiovascular

PRE-DETERMINE Cohort Study

New York : Columbia University Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

New York : Mount Sinai School of Medicine

The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery

New York : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New York, : New York Presbyterian Hospital

Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device

Poughkeepsie : Hudson Valley Heart Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Roslyn : St. Francis Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Stony Brook : Stony Brook University Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Stony Brook : Stony Brook Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Syracuse : St. Joseph's Hospital Health Center

Resolute Integrity US

Utica : St. Elizabeth Medical Center - Hotvedt

PRE-DETERMINE Cohort Study

Utica : St. Elizabeth Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Utica : Central New York Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Valhalla : Westchester Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Westfield : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Williamsville : Buffalo Cardiology and Pulmonary Associates, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Williamsville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Asheville : Asheville Cardiology Associates

PRE-DETERMINE Cohort Study

Asheville : Asheville Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Charlotte : UNC School of Medicine

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Charlotte : Mid-Carolina Cardiology Presbyterian Hospital Updated

PROMUS Element Plus US Post-Approval Study

Charlotte : Mid Carolina Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Charlotte : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Durham : Duke University Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Durham : Veterans Affairs Medical Center, Duke University Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Durham : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Elizabeth City : Eastern Carolina Cardiovascular

PRE-DETERMINE Cohort Study

Gastonia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Greensboro : LeBauer Cardiovascular Research Foundation

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Greensboro : Moses H. Cone Memorial Hospital-LeBauer Cardiovascular Research Foundation

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

High Point : Carolina Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Lenoir : Northstate Clinical Research

PRE-DETERMINE Cohort Study

Matthews : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pinehurst : Pinehurst Medical Clinic, Inc.

PRE-DETERMINE Cohort Study

Raleigh : Wake Heart Research

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Raleigh : Rex Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Raleigh : Wake Heart Research, LLC

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Salisbury : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sanford : Sanford Cardiology

PRE-DETERMINE Cohort Study

Statesville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wake Forest : Triangle Primary Care

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Wilmington : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Winston-Salem : Wake Forest

PRE-DETERMINE Cohort Study

Winston-Salem : Forsyth Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Grand Forks : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Akron : Northeast Ohio Cardiovascular Specialists

PRE-DETERMINE Cohort Study

Cincinnati : The Christ Hospital

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System

Cincinnati : University of Cincinnati

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Cincinnati : The Lindner Clinical Trial Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Cincinnati : University of Cincinnati Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Cincinnati : University of Cincinnati

PRE-DETERMINE Cohort Study

Cincinnati : Lindner Center for Research and Education at Christ Hosp

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Cincinnati : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cincinnatti : The Christ Hospital Lindner Research Center Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Cleveland : University Hospitals Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Cleveland : Cleveland Clinic Foundation

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Cleveland : Cleveland Clinic Foundation

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Cleveland : University Hospital of Cleveland, Harrington-McLaughlin Heart and Vascular Institute

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Cleveland : The MetroHealth System

PRE-DETERMINE Cohort Study

Cleveland : The Cleveland Clinic Foundation

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Cleveland : The Cleveland Clinic Foundation

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Cleveland : University Hospitals of Cleveland

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Cleveland : University Hospitals of Cleveland

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Columbus : OhioHealth Research Institute

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Columbus : The Ohio State University

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Columbus : Ohio State University Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Columbus : Ohio Health Research Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Columbus : Ohio State Univeristy

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Elyria : North Ohio Research, Ltd.

PRE-DETERMINE Cohort Study

Elyria : EMH Regional Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Elyria : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Fairfield : Mercy Medical Associates

PRE-DETERMINE Cohort Study

Garfield Heights : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kettering : Kettering Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Middleburg Heights : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sandusky : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Toledo : Northwest Ohio Cardiology Consultants/The Toledo Hospital

PRE-DETERMINE Cohort Study

Toledo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Westlake : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Youngstown : Comprehensive Physicians Associates

Investigation of a Novel Gene Expression Test for the Diagnosis of Obstructive Coronary Artery Disease on Physician's Practice Pattern

Zanesville : Cardiology Associates of Southeast Ohio, Inc.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Oklahoma City : Oklahoma Heart Hospital Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Oklahoma City : Oklahoma City VA Medical Center Veterans Research and Education Foundation

PRE-DETERMINE Cohort Study

Oklahoma City : Oklahoma Foundation for Cardiovascular Research

PRE-DETERMINE Cohort Study

Oklahoma City : Oklahoma City Veterans' Affairs Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Oklahoma City : South Oklahoma Heart Research

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Oklahoma City : Oklahoma Heart Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Oklahoma City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tulsa : St. Francis Hospital Updated

PROMUS Element Plus US Post-Approval Study

Tulsa : Oklahoma Heart Institute at Utica

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Portland :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Portland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Abington : Abington Memorial Hospital

PRE-DETERMINE Cohort Study

Beaver : The Heart and Vascular Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Beaver : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bethlehem : St. Luke's Bethlehem

PRE-DETERMINE Cohort Study

Danville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Doylestown : Doylestown Cardiology Associates

PRE-DETERMINE Cohort Study

Doylestown : Doylestown Hospital Updated

PROMUS Element Plus US Post-Approval Study

Doylestown : Central Bucks Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Doylestown : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Erie : Saint Vincent Health Care Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Erie : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Harrisburg : Pinnacle Health Cardiovascular Institute/ Associated Cardiologists

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Harrisburg : Pinnacle Heart & Vascular Institute

An Observational Study of Cholesterol in Coronary Arteries

Harrisburg : Pinnacle Health Cardiovascular Insititute

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Jersey Shore : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lancaster :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Lancaster : Lancaster Heart & Stroke Foundation

PRE-DETERMINE Cohort Study

Lewistown : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Philadelphia : Temple University Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Philadelphia : Jefferson Heart Institute

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

Philadelphia : Drexel University College of Medicine

PRE-DETERMINE Cohort Study

Philadelphia : Presbyterian University of Pennsylvania Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Philadelphia : University of Pennsylvania

Stem Cell Implantation in Patients Undergoing CABG

Philadelphia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pittsburg : University of Pittsburg Medical Center - Presbyterian Hospital Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Pittsburgh : Allegheny General Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Pittsburgh : Presbyterian University Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Pittsburgh : UPMC Presbyterian Hospital

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Pittsburgh : University of Pittsburgh Medical Center

Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events

Pittsburgh : University of Pittsburgh Medical Center

PITT PCI Xience Registry

Pittsburgh : University of Pittsburgh Medical Center

PRE-DETERMINE Cohort Study

Pittsburgh : Allegheny-Singer Research Institute (Allegheny General Hospital)

PRE-DETERMINE Cohort Study

Pittsburgh : Veterans Administration Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Pittsburgh : Allegheny-Singer Research Institute

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Pittsburgh : University of Pittsburgh Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Pittsburgh : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Port Matilda : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sayre : Donald Guthrie Foundation for Education and Research

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Scranton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sellersville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wilkes-Barre : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wormleysburg : Pinnacle Health System

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Wyomissing : Berks Cardiologists, Ltd.

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

York : York Hospital /Wellspan Health

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

York : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Providence : Rhode Island Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Providence : Rhode Island Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Providence : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Anderson : AnMed Health

PRE-DETERMINE Cohort Study

Charleston : Medical University of South Carolina

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Charleston : Medical University of South Carolina Hospital

An Observational Study of Cholesterol in Coronary Arteries

Charleston : Medical University of South Carolina Hospital

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Charleston : VA Medical Center - Charleston

PRE-DETERMINE Cohort Study

Charleston : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Charlston :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Columbia : Columbia Cardiology Consultants

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Columbia : Sisters of Charity Providence Hospitals

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Greenville : St. Francis Health System - St. Francis Hospital Updated

PROMUS Element Plus US Post-Approval Study

Greenville : University Medical Center-Greenville Memorial Hospital Updated

PROMUS Element Plus US Post-Approval Study

Greenville : Upstate Cardiology

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Myrtle Beach : Grand Strand Regional Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Rock Hill : Carolina Cardiology Associates

PRE-DETERMINE Cohort Study

Spartanburg : Spartanburg Regional Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Spartanburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rapid City : Black Hills Cardiovascular Research

PRE-DETERMINE Cohort Study

Rapid City : Rapid City Regional Hospital Updated

PROMUS Element Plus US Post-Approval Study

Rapid City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sioux Falls : Avera Heart Hospital of South Dakota Updated

PROMUS Element Plus US Post-Approval Study

Sioux Falls : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bristol : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jackson : Research Associates of Jackson

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Johnson City : Cardiology Consultants

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Johnson City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kingsport : Wellmont CVA Heart Institute

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Knoxville : Cardiovascular Research of Knoxville - St. Mary's Health Care System, Inc.

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Knoxville : Center for Biomedical Research

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Knoxville : Tennova Healthcare - Turkey Creek Medical Center Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Knoxville : Cardiovasular Research of Knoxville

PRE-DETERMINE Cohort Study

Knoxville : Cardiovascular Research of Knoxville

PRE-DETERMINE Cohort Study

Knoxville : University of Tennessee

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Memphis : Memphis VA Medical Center

PRE-DETERMINE Cohort Study

Memphis : Stern Cardiovascular Foundation

PRE-DETERMINE Cohort Study

Memphis : Methodist University Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Nashville : Vanderbilt Heart and Vascular Institute

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Nashville :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Nashville : Centennial Heart Cardiovascular Consultants, LLC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Nashville : St. Thomas Hospital Heart

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Nashville : Vanderbilt Medical Center

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Amarillo : Cardiology Center of Amarillo, LLP

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Austin : South Austin Hospital Updated

PROMUS Element Plus US Post-Approval Study

Austin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Beaumont : Research Site

A Pharmacodynamic Study With Ticagrelor in African American Patients

Corpus Christi/Texas : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dallas : Dallas VA Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Dallas :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Dallas : Veterans Affairs, North Texas Health Care Systems

An Observational Study of Cholesterol in Coronary Arteries

Dallas : Veterans Affairs North Texas Health Care Systems

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Dallas : CRSTI/Medical City Dallas

Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques

Dallas : Presbyterian Hospital of Dallas Updated

PROMUS Element Plus US Post-Approval Study

Dallas : VA North Texas Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Dallas : North Texas Healthcare System, Dept. of Veteran's Affairs

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Dallas : Medical City Hospital

Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique

Dallas : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Galveston : University of Texas Medical Branch

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Georgetown : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Harker Heights : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Houston : Excel Diagnostics and Nuclear Oncology Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Houston : Texas Heart Institute at St. Luke's Episcopal Hospital Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Houston : The Methodist Hospital

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Houston : Texas Heart Institute

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Houston : Texas Heart Institute, St. Luke's Episcopal Hospital

LifeVest Post-CABG Registry

Houston : Non-Invasive Cardiovascular PA

PRE-DETERMINE Cohort Study

Houston : St. Luke's Episcopal Hospital

PRE-DETERMINE Cohort Study

Houston : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Humble : Humble Cardiology Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Katy : Katy Cardiology

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Mission : Gamma Medical Research Inc.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Plano : The Heart Hospital Baylor Plano

Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques

Plano : The Heart Hospital Baylor Plano

Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique

Plano : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Antonio : Novartis Investigative Site

Efficacy of LCQ908 on Cardiovascular Risk

San Antonio : San Antonio Endovascular and Heart Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

San Antonio : South Texas Cardiovascular Consultants

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

San Antonio : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Temple : Scott & White Memorial Hospital

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Temple : Scott & White Memorial Hospital

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Tomball : West Houston Area Clinical Trial Consultants, LLC

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Tyler : Cardiovascular Associates of East Texas

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Victoria : Victoria Heart and Vascular Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Victoria : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Waco : Providence Health Center

PRE-DETERMINE Cohort Study

Draper : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Layton : Utah Cardiology, PC

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Murray : Intermountain Medical Center

PRE-DETERMINE Cohort Study

Ogden : McKay-Dee Heart Services

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Salt Lake City : University of Utah

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Salt Lake City : Intermountain Healthcare

Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64

Burlington : Fletcher Allen Health Care

Cangrelor Ticagrelor Transition Study

Burlington : University of Vermont Medical Center, Fletcher Allen Health Care

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Burke : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Charlottesville : University of Virginia Health System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Charlottesville : University of Virginia

Detection of Coronary Artery Disease Using Analysis of High Frequency QRS: The HyperQ Registry

Charlottesville : University of Virginia

Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus

Falls Church : Inova Heart and Vascular Institute

CorMatrix ECM Study: To Identify Inflammatory Markers Following CABG With/Without ECM

Norfolk : Sentara Cardiovascular Research Institute Updated

A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System

Norfolk : Sentara Cardiovascular Research Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Norfolk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Richmond : McGuire Veteran Affairs Medical Center

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Richmond : Chippenham Medical Center Updated

PROMUS Element Plus US Post-Approval Study

Richmond : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Roanoke : Carilion Cardiology Clinic

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Roanoke : Roanoke Heart Institute

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Roanoke : Carilion Roanoke Memorial Hospital Updated

PROMUS Element Plus US Post-Approval Study

Virginia Beach : Cardiovascular Associates Virginia Beach

PRE-DETERMINE Cohort Study

Virginia Beach : Cardiovascular Associates, Ltd.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Winchester : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kirkland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Olympia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Renton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Seattle : Swedish Medical Center

An Observational Study of Cholesterol in Coronary Arteries

Seattle : Swedish Medical Center

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Seattle : University of Washington

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Seattle : The Heart Institute at Virginia Mason

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Seattle : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Seattle : University of Washington Coronary Atherosclerosis Research Lab

Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)

Spokane : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tacoma : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Walla Walla : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wenatchee : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Yakima : Yakima Heart Center

Using Magnetic Resonance Imaging to Evaluate Carotid Artery Plaque Composition in People Receiving Cholesterol-Lowering Medications (The CPC Study)

Madison : University of Wisconsin Hospitals

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Madison : Meriter Hospital Updated

PROMUS Element Plus US Post-Approval Study

Milwaukee : Aurora Health Care

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina

Wausau : Aspirus Heart & Vascular Institute

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Wausau : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Adrogue : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bahia Blanca : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Buenos Aires : Instituto Cardiovascular de Buenos Aires-ICBA

ABSORB EXTEND Clinical Investigation

Buenos Aires : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Buenos Aries : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Caba : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ciudad Autonoma de Buenos Aires :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cordoba : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Córdoba :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Corrientes : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Junin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

La Plata : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mar del Plata : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mendoza : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ramos Mejia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rosario : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Santa Fe : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tucuman : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Adelaide : Royal Adelaide Hospital

ABSORB PHYSIOLOGY Clinical Investigation

Auchenflower : Wesley Hospital

ABSORB EXTEND Clinical Investigation

Auchenflower : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ballarat : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bedford Park : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Camperdown, NSW :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Caulfield South : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Coffs Harbour : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Concord : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Epping : Northern Hospital

Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms

Frankston : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Fremantle : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Garran, ACT : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Gosford : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Heidelberg : Austin Health

ABSORB PHYSIOLOGY Clinical Investigation

Joondalup : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kippa Ring : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Liverpool : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Malvern : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Melbourne : St. Vincent's Hospital

ABSORB EXTEND Clinical Investigation

Melbourne : Monash Medical Centre

ABSORB PHYSIOLOGY Clinical Investigation

Nedlands : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Perth :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Randwick : Eastern Heart Clinic, The Prince of Wales Hospital

ABSORB EXTEND Clinical Investigation

Sherwood : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

South Brisbane :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Southport QLD :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Victoria : Monash Medical Center

ABSORB EXTEND Clinical Investigation

Graz : Landeskrankenhaus Graz West

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Innsbruck : Innsbruck Universitaetsklinik

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Linz : Allgemeines Krankenhaus Linz

ABSORB EXTEND Clinical Investigation

Linz : Allgemeines Krankenhaus der Stadt Linz

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Saint Pölten : Landesklinikum Sankt Pölten

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Vienna : AKH Wien

BIOFLOW-III Austria Satellite Registry

Vienna : Krankenhaus Hietzing

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Wien : Medizinische Universität Wien

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Wien : Wilhelminenspital der Stadt Wien

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Aalst : Onze-Lieve VrouweZiekenhuis

ABSORB EXTEND Clinical Investigation

Aalst : OLV Ziekenhuis Aalst

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

Aalst : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Antwerp : Ziekenhuis Netwerk Antwerpen Middelheim

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Antwerpen : ZNA Middelheim

Safety and Effectiveness of the Coronary Momo Stent

Antwerpen : Middelheim Ziekenhuis

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

Antwerpen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Antwerpen, Linderreef 1 : Academic Hospital Middelheim

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Bonheiden : Imelda Ziekenhuis

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bonheiden : Imelda vzw

Safety and Effectiveness of the Coronary Momo Stent

Bonheiden : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Brugge : Algemeen Ziekenhuis Sint-Jan

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Brugge : AZ Sint Jan

Safety and Effectiveness of the Coronary Momo Stent

Brussel : UZ Brussel

Safety and Effectiveness of the Coronary Momo Stent

Brussels : Abbott Vascular International BVBA

ABSORB FIRST Registry

Brussels : Abbott Vascular International BVBA

ABSORB II Randomized Controlled Trial

Bruxelles : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Edegem :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Genk : ZOL Genk, Campus Saint Jan

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Genk : Ziekenhuis Oost-Limburg

Safety and Effectiveness of the Coronary Momo Stent

Genk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Gent : AZ Maria Middelares

Safety and Effectiveness of the Coronary Momo Stent

Haine St. Paul :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Hasselt : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

La Louvière : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Leuven :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Leuven : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Liege : Centre Hospitalier Universitaire Sart Tilman Liège

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Liège : CHU Liège - Sart Tilman

Acrobat Coronary Stent System Effectiveness European Study

Liège : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Roeselaere : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Yvoir : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Belo Horizonte : Irmandade Santa Casa de Misericórdia de Belo Horizonte

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Belo Horizonte : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Blumenau : Hospital Santa Isabel

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Campinas : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Colatina - ES : São Bernardo Apart Hospital

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Curitiba : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Franca - SP : Santa Casa de Franca

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Goiânia : Hospital São Salvador Goiânia

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Goiânia : Hospital Santa Genoveva

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Goiânia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Natal : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Patos de Minas - MG : Hospital Vera Cruz

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Pelotas : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Porto Alegre : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Recife - PE : Instituto de Medicina Integral Professor Fernando Figueira - IMIP

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Rio de Janeiro :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Rio de Janeiro : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Salvador : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

São José do Rio Preto : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

São José do Rio Preto - SP : Santa Casa de Misericórdia de São José do Rio Preto

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

Sao Paulo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Sao Paulo : Sociedade Beneficente Isreaelita Brasileira Hospital Albert Einstein

ABSORB EXTEND Clinical Investigation

Sao Paulo : Instituto de Cardiologia Dante Pazzanese Unidadae II Recepcao de Angioplastia

ABSORB EXTEND Clinical Investigation

Sao Paulo : Instituto Dante Pazzanese de Cardiologia

Safety Study of a Bioresorbable Coronary Stent

São Paulo : Hospital São Paulo - UNIFESP

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

São Paulo : Instituto de Assistência Médica ao Servidor Público Estadual - Iamspe

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

São Paulo : Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

São Paulo : Instituto Dante Pazzanese de Cardiologia

Study to Evaluate the Safety of Cronus® - Cobalt Chromium Coronary Stent

São Paulo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Uberlandia : Instituto Coração Triângulo Mineiro

ABSORB EXTEND Clinical Investigation

Dimitrovgrad : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pleven : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Plovdiv : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ruse : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sofia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Veliko Tarnovo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ajax : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bay Roberts : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Brampton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chicoutimi :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Edmonton : University of Alberta and Mazankowski Alberta Heart Institute

Autologous Cell Therapy for Ischemic Heart Failure

Edmonton : Royal Alexandra Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Edmonton : University of Alberta Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Edmonton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Gatineau : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Greenfield Park : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Halifax : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hamilton : Hamilton Health Sciences, General Site

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Hamilton : Hamilton Health Sciences

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Hamilton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kelowna : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kitchener : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Levis : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

London : University of Western Ontario

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Mississauga : KMH Cardiology and Diagnostic and MRI Centres

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Mississauga : Entralogix Clinical Research, Inc.

PRE-DETERMINE Cohort Study

Mississauga : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Montreal :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Montreal : Montreal Heart Institute

ABSORB EXTEND Clinical Investigation

Montreal : Montreal Heart Institute

Autologous Cell Therapy for Ischemic Heart Failure

Montreal : Centre Hospitalier de l'Universite de Montreal (CHUM)

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Montreal : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Montreal : Innovaderm Research Inc

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Montréal : Hôpital du Sacré-Coeur de Montréal

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Montréal : Montreal Heart Institute

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

New Westminister : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New Westminster : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oshawa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ottawa : University of Ottawa Heart Institute

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Ottawa : University of Ottawa Heart Institute

ABSORB EXTEND Clinical Investigation

Ottawa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Quebec : Institut Universitaire de Cardiologie et de Pneumologie de Québec

ABSORB EXTEND Clinical Investigation

Quebec City : Institut Universitaire de Cardiologie et de Pneumologie de Québec

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Quebec City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Saint Charles-Borromee : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Saint John : New Brunswick Heart Centre

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Sainte-Foy :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Scarborough : Scarborough Cardiology Research Associates

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke (CHUS)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Sherbrooke : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St. John's : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St-Hyacinthe : Clinique Médicale Dr Isabelle Delorme

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Surrey : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Thornhill : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Toronto : St. Michael's Hospital

ABSORB EXTEND Clinical Investigation

Toronto : Saint Michael's Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Toronto : University Health Network

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Toronto : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Trois Rivières : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Truro : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Vancouver :

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Vancouver : Vancouver General Hospital

PRE-DETERMINE Cohort Study

Vancouver : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Victoria : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Winnipeg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Santiago : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Talcahuano : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Viña del Mar : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Anshan : The Central Hospital of Anshan

Acarbose Cardiovascular Evaluation Trial

Baotou : Baotou Central Hospital

Acarbose Cardiovascular Evaluation Trial

Baotou : The First Affiliated Hospital of Baotou Medical College

Acarbose Cardiovascular Evaluation Trial

Beijing : Aerospace Central Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Affiliated to The Capital University of Medical Sciences Beijing Friendship Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Anzhen Hospital of The Capital University of Medical Sciences

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Pinggu Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Yangfangdian Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : China Meitan General Hospita

Acarbose Cardiovascular Evaluation Trial

Beijing : China-Japan Friendship Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Peking University People's Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Anzhen Hospital of The Capital University of Medical Sciences 2nd.

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Healthy Palace Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Ji Shui Tan Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Shijingshan Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Beijing Yanhua Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Fu Xing Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : General Hospital of Second Artillery PLA

Acarbose Cardiovascular Evaluation Trial

Beijing : Peking Union Medical College Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : PLA General Hospital

Acarbose Cardiovascular Evaluation Trial

Beijing : Fuwai Cardiovascular Hospital

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Beijing : Cardiology department ,Beijing Anzhen hospital

Fluvastatin AmelIorates aTHerosclerosis Study

Beijing : For Recruiting Locations in

Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

Beijing : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Changchun : China-Japan Union Hospital of Jilin University

Acarbose Cardiovascular Evaluation Trial

Changchun : The Second Hospital of Jilin University

Acarbose Cardiovascular Evaluation Trial

Changsha : Hunan Provincial People's Hospital

Acarbose Cardiovascular Evaluation Trial

Changsha : Xiangya Hospital Central-South University

Acarbose Cardiovascular Evaluation Trial

Changsha : The Fourth Hospital of Changsha

Acarbose Cardiovascular Evaluation Trial

Changsha : The Third Hospital of Changsha

Acarbose Cardiovascular Evaluation Trial

Chengdu : The West China Hospital

Acarbose Cardiovascular Evaluation Trial

Chengdu : Chengdu First People's Hospital

Acarbose Cardiovascular Evaluation Trial

Chengdu : Chengdu Second People's Hospital

Acarbose Cardiovascular Evaluation Trial

Chengdu : Sichuan Provincial People's Hospital

Acarbose Cardiovascular Evaluation Trial

Chongqing : Chongqing Medical University Second Afflicated Hospital

Acarbose Cardiovascular Evaluation Trial

Chongqing : Chongqing Third People's Hospital

Acarbose Cardiovascular Evaluation Trial

Chongqing : Da Ping Hospital

Acarbose Cardiovascular Evaluation Trial

Chongqing : The Second People's Hospital of Chongqing

Acarbose Cardiovascular Evaluation Trial

Chongqing : Chongqing Zhongshan Hospital

Acarbose Cardiovascular Evaluation Trial

Da Qing : Da Qing Oilfield General Hospital

Acarbose Cardiovascular Evaluation Trial

Dalian : Dalian Central Hospital

Acarbose Cardiovascular Evaluation Trial

Dalian : The First Hospital of Dalian Medical University

Acarbose Cardiovascular Evaluation Trial

Fuzhou : Fujian Provincial Hospital

Acarbose Cardiovascular Evaluation Trial

Fuzhou : The People's Hospital of Fujian Province

Acarbose Cardiovascular Evaluation Trial

Guangzhou : The First Affiliated Hospital of Guangdong Pharmaceutical University

Acarbose Cardiovascular Evaluation Trial

Guangzhou : The First Affiliated Hospital of Sun Yat-Sen University

Acarbose Cardiovascular Evaluation Trial

Guangzhou : The Second Affiliated Hospital of Zhongshan University

Acarbose Cardiovascular Evaluation Trial

Guangzhou : The First Affiliated Hospital of jinan University

Acarbose Cardiovascular Evaluation Trial

Guangzhou : The Third Affiliated Hospital of Guangzhou Medical College

Acarbose Cardiovascular Evaluation Trial

Guangzhou : Guangdong General Hospital

Acarbose Cardiovascular Evaluation Trial

Guangzhou : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Guangzhou : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Guiyang : The Affiliated Hospital of Guiyang Medical College

Acarbose Cardiovascular Evaluation Trial

Haerbin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hang Zhou : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hangzhou : Zhe Jiang Hospital

Acarbose Cardiovascular Evaluation Trial

Hangzhou : Sir Run Run Shaw Hospital Affiliated With School of Medicine,Zhe Jiang University

Acarbose Cardiovascular Evaluation Trial

Harbin : The Fourth Affiliated Hospital of Harbin Medical University

Acarbose Cardiovascular Evaluation Trial

Hohhot : Inner Mongolia Hospita

Acarbose Cardiovascular Evaluation Trial

Hong Kong : Queen Mary Hospital

ABSORB EXTEND Clinical Investigation

Hong Kong : Prince of Wales Hospital

ABSORB EXTEND Clinical Investigation

Hongkong : Prince of Wales Hospital

Acarbose Cardiovascular Evaluation Trial

Jinan : The Central Hospital of Jinan

Acarbose Cardiovascular Evaluation Trial

Jinan : The First People's Hospital of Jinan

Acarbose Cardiovascular Evaluation Trial

Jinan : The General Hospital of Jinan Military Region

Acarbose Cardiovascular Evaluation Trial

Jinan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kunming : The First Affiliated Hospital of Kunming Medical College

Acarbose Cardiovascular Evaluation Trial

Kunming : The First People's Hospital of Yunnan Province

Acarbose Cardiovascular Evaluation Trial

Kunming : The Second Affiliated Hospital of Kunming Medical College

Acarbose Cardiovascular Evaluation Trial

Linyi : Linyi People's Hospital

Acarbose Cardiovascular Evaluation Trial

Liuzhou : Liuzhou People's Hospital

Acarbose Cardiovascular Evaluation Trial

Luoyang : The First Affiliated Hospital of Henan Science & Technology University

Acarbose Cardiovascular Evaluation Trial

Nanchang : The Third Affiliated Hospital of Nanchang University

Acarbose Cardiovascular Evaluation Trial

Nanchang : Jiangxi Provincial People's Hospital

Acarbose Cardiovascular Evaluation Trial

Nanchang : The Second Affiliated Hospital of Nanchang University

Acarbose Cardiovascular Evaluation Trial

NanJing : 81st Hospital of Chinese PLA

Acarbose Cardiovascular Evaluation Trial

Nanjing : BENQ Hospital

Acarbose Cardiovascular Evaluation Trial

NanJing : Jiangsu Provincial Hospital of TCM

Acarbose Cardiovascular Evaluation Trial

Nanjing : Nanjing First Hospital

Acarbose Cardiovascular Evaluation Trial

Nanjing : Nanjing Zhongda Hospital

Acarbose Cardiovascular Evaluation Trial

Nanjing : Jiangsu Province Hospital

Acarbose Cardiovascular Evaluation Trial

NanJing : Jiangsu Province Official Hospital

Acarbose Cardiovascular Evaluation Trial

Nanjing : Nanjing Drum Tower Hospital

Acarbose Cardiovascular Evaluation Trial

Nanjing : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nanjing, : Nanjing Jiangning Hospital

Acarbose Cardiovascular Evaluation Trial

Nanning : 303 Hospital of People's Liberation Army

Acarbose Cardiovascular Evaluation Trial

Nanning : Minzu Hospital of Guangxi Zhuang Autonomous Region

Acarbose Cardiovascular Evaluation Trial

Nanning : The First Affiliated Hospital of Guangxi Medical University

Acarbose Cardiovascular Evaluation Trial

Qingdao : The Qingdao Municiple Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Number 411 Hospital of PLA

Acarbose Cardiovascular Evaluation Trial

Shanghai : Putuo District Center Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Renji Hospital Affilicated to Jiaotong University School of Medicine

Acarbose Cardiovascular Evaluation Trial

Shanghai : Ruijin Hospital Affiliated to the Shanghai Jiaotong University Medical School

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Central Hospital of Xuhui District

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Jinshan Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Ninth People's Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Putuo District People's Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Tongji Hospital of Tongji University

Acarbose Cardiovascular Evaluation Trial

Shanghai : Changhai Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Central Hospital of Yangpu District

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai East Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Huadong Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Pudong New District People's Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Tenth People's Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Shanghai Zhabei District Shibei Hospital

Acarbose Cardiovascular Evaluation Trial

Shanghai : Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Acarbose Cardiovascular Evaluation Trial

Shanghai : Zhongshan Hospital

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial

Shanghai : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Shenyang : The Fourth Hospital of China Medical University

Acarbose Cardiovascular Evaluation Trial

Shenyang : Shengjing Hospital of China Medical University

Acarbose Cardiovascular Evaluation Trial

Shenzhen : Peking University Shenzhen Hospital

Acarbose Cardiovascular Evaluation Trial

Shihezi : First Affiliated Hospital of the Medical College

Acarbose Cardiovascular Evaluation Trial

Shijiazhuang : Bethune International Peace Hospital

Acarbose Cardiovascular Evaluation Trial

Shijiazhuang : The Second Hospital of Hebei Medical University

Acarbose Cardiovascular Evaluation Trial

Shijiazhuang : The First Hospital of Hebei Medical University

Acarbose Cardiovascular Evaluation Trial

Suzhou : Suzhou Municipal Hospital

Acarbose Cardiovascular Evaluation Trial

Taian : Taian City Central Hospital

Acarbose Cardiovascular Evaluation Trial

Taiyuan : Shanxi Cardiovascular Hospital

Acarbose Cardiovascular Evaluation Trial

Taiyuan : General Hospital of Tisco

Acarbose Cardiovascular Evaluation Trial

Taiyuan : Taiyuan City Central Hospital

Acarbose Cardiovascular Evaluation Trial

Taiyuan : The Third Engineering Bureau Hospital of Ministry of Railway

Acarbose Cardiovascular Evaluation Trial

Tangshan : Tangshan Workers Hospital

Acarbose Cardiovascular Evaluation Trial

Tangshan : The Affiliated Hospital of North China Coal Medical University

Acarbose Cardiovascular Evaluation Trial

Tangshan : Yu Tian County Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : Army Police's Medical College Affiliated Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : Dagang Oil-Field General Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : The Second Hospital of Tianjin Medical University

Acarbose Cardiovascular Evaluation Trial

Tianjin : Tianjin First Center Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : Tianjin Union Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : The Fifth Central Hospital of Tianjin

Acarbose Cardiovascular Evaluation Trial

Tianjin : Tianjin Chest Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : Tianjin Third Central Hospital

Acarbose Cardiovascular Evaluation Trial

Tianjin : Tianjin Union Medicine Centre

Acarbose Cardiovascular Evaluation Trial

Urumqi : The 474th Hospital of PLA

Acarbose Cardiovascular Evaluation Trial

Urumqi : General Hospital of Xinjiang Production and Construction Corps

Acarbose Cardiovascular Evaluation Trial

Urumqi : The First Teaching Hospital of Xinjiang Medical University

Acarbose Cardiovascular Evaluation Trial

Wuhan : Union Hospital of Tongji Medical College of Huazhong

Acarbose Cardiovascular Evaluation Trial

Wuhan : Pu'ai Hospital of Wuhan City

Acarbose Cardiovascular Evaluation Trial

Wuhan : Renmin Hospital of Wuhan Univdrsity

Acarbose Cardiovascular Evaluation Trial

Wuhan : Wuhan Asia Heart Hospital

Acarbose Cardiovascular Evaluation Trial

Wuhan : Zhongnan Hospital of Wuhan University

Acarbose Cardiovascular Evaluation Trial

Wuhan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wuhan, : Tongji Hospital of Tongji Medical College of Huazhong

Acarbose Cardiovascular Evaluation Trial

Wuxi : Wuxi No.3 People's Hospital

Acarbose Cardiovascular Evaluation Trial

Wuxi : Wuxi People's Hospital

Acarbose Cardiovascular Evaluation Trial

Wuxi : Wuxi No.2 People's Hospital

Acarbose Cardiovascular Evaluation Trial

Xiamen : The First Hospital of Xiamen

Acarbose Cardiovascular Evaluation Trial

Xiamen : Zhongshan Hospital Xiamen University

Acarbose Cardiovascular Evaluation Trial

Xian : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Xi'an : Affiliated Hospital of Xi'an Medical college

Acarbose Cardiovascular Evaluation Trial

Xi'an : The First Affiliated Hospital of Xi'an Jiaotong University

Acarbose Cardiovascular Evaluation Trial

Xi'an : Xi'an Central Hospital

Acarbose Cardiovascular Evaluation Trial

Yanan : Yan'an People' Hospital

Acarbose Cardiovascular Evaluation Trial

Yan'an : Affiliated Hospital of Yan'an University

Acarbose Cardiovascular Evaluation Trial

Yinchuan : The People's Hospital of Ningxia Hui Autonomous Region

Acarbose Cardiovascular Evaluation Trial

Yinchuan : Affiliated Hospital of Ningxia Medical University

Acarbose Cardiovascular Evaluation Trial

Yinchuan : The First Hospital of Yinchuan

Acarbose Cardiovascular Evaluation Trial

Yulin : The First Hospital of Yulin

Acarbose Cardiovascular Evaluation Trial

Zhangjiakou : The Third Affiliated Hospital of Hebei North University

Acarbose Cardiovascular Evaluation Trial

Zhanjiang : Zhanjiang First People's Hospital

Acarbose Cardiovascular Evaluation Trial

Zhengzhou : The First Affiliated Hospital of Henan College of TCM

Acarbose Cardiovascular Evaluation Trial

Zhengzhou : The People's Hospital of Zhengzhou

Acarbose Cardiovascular Evaluation Trial

ZhengZhou : The Second Affiliated Hospital of Zhengzhou University

Acarbose Cardiovascular Evaluation Trial

Zhongshan : Zhong Shan City People's Hospital

Acarbose Cardiovascular Evaluation Trial

Zhuhai : The Fifth Affiliated Hospital of Sun Yat-Sen University

Acarbose Cardiovascular Evaluation Trial

Osijek :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Zagreb :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Brno : Fakultní nemocnice Brno

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Caslav : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chomutov : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chrudim : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hradec Kralove :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Jihlava : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Karlovy Vary : Karlovarská krajská nemocnice a.s.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kladno : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kolin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kromeriz : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Liberec : Krajská nemocnice Liberec a.s.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Milevsko : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pisek : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Prague : General University Hospital

GLP-1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Diabetic Patients With Aortocoronary Bypass

Praha 1 :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Praha 2 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Slany : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Svitavy : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tabor : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Usti nad Orlici : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Aarhus : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Århus N : Århus University Hospital

ABSORB EXTEND Clinical Investigation

Esbjerg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Koebenhavn OE : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Silkeborg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Skejby : Aarhus University Hospital

The Nordic-Baltic Bifurcation Study IV

Tallinn : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tartu : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Helsinki : Helsinki University Hospital

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Turku : Turku PET Centre

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Aix en Provence cedex 1 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Annecy : Centre Hospitalier de la Région Annecienne

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Arras : Centre Hospitalier d'Arras

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Avignon : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Besançon Cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bron : Hôpital Cardiovasculaire et Pneumologique Louis Pradel

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Bron Cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Colmar : Hôpital Albert Schweitzer

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Corbeil Essonnes : Centre Hospitalier Sud Francilien

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Créteil : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dijon : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Haguenau : Centre Hospitalier d'Haguenau

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Lille Cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lyon : Centre Hospitalier Saint Joseph et Saint Luc

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Marseille cedex 5 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Massy : Hôpital Privé Jacques Cartier

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Metz Cedex 03 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Montpellier : Hôpital Arnaud de Villeneuve

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Nantes Cedex 1 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Narbonne Cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nimes : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nîmes : Centre Hospitalier Universitaire Caremeau

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Ollioules : Polyclinique les Fleurs

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Paris : Hôpital Européen Georges Pompidou

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Paris : Groupe Hospitalier Pitié Salpêtrière

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Paris : Hôpital Bichat-Claude Bernard

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Paris : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Paris : Centre Hospitalo-Universitaire Pitié-Salpetrière

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Paris Cedex 13 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Paris Cedex 18 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pessac : Hôpital Haut Leveque

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Pessac : Hôpital du Haut-Lévêque

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Pessac cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pontoise : Centre Hospitalier Rene Dubos

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Pringy : Centre Hospitalier d'Annecy

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Rennes : Hôpital Pontchaillou

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Roubaix : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Strasbourg : Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Strasbourg cedex : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Toulouse : Hôpital Rangueil

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Toulouse : Clinique Pasteur

ARTDIVA Study : First in Man Safety Evaluation of the ART18Z Bioresorbable Stent

Toulouse : Centre Hospitalier de Rangueil

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Toulouse Cedex 09 : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Toulouse Cedex 9 : Hôpital Rangueil

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tourcoing : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Villeneuve Saint Georges : CHI de Villeneuve

Genotyping Infarct Patients to Adjust and Normalize Thienopyridine Treatment

Aachen :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Aachen : Universtiy Hospital of Aachen, Department of Cardiology

Heart Cycle GEx (Guided- Exercise- Main Trial)

Aachen : University Hospital Aachen

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Aschaffenburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bad Nauheim : Kerckhoff-Klinik SGmbh

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

Bad Nauheim : Kerckhoff-Klinik GmbH

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bad Oeynhausen : Herz- und Diabeteszentrum Nordrhein Westfalen

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Bad Oeynhausen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bad Segeberg : Herzzentrum Bad Segeberger Klinik

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Berlin :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Berlin : Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Berlin : Innere Medizin Kardiologie - Charité Centrum 11, Campus Benjamin Franklin

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Berlin : Deutsches Herzzentrum Berlin

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Berlin : Vivantes Klinikum im Friedrichshain

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Berlin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bernau : Herzzentrum Brandenburg in Bernau

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Bernau : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bielefeld : Städtische Kliniken Bielefeld gGmbH

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bochum : University Hospital of Bochum, Department of Dermatology

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Bonn : Arzt St. Marien-Hospital Abt. Innere Medizin

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

Bremen : Klinikum Links der Weser - Senator-Wessling-Str. 1

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Coburg : Klinikum Coburg GmbH

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Coburg : Kardiologie - Angiologie - Pneumologie, Klinikum Coburg

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Deggingen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Delitzsch : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dorsten : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dortmund : HIV Outpatient Department

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Dortmund : Sankt Johannes Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Dresden : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Duisburg : Health Center

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Eschweiler : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Essen : Elisabeth-Krankenhaus Essen GmbH

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Essen : University Hospital, West German Heart Center Essen

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Essen : University Hospital, Department of Dermatology and Venerology

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Essen : Contilia Heart- and Vascular Center, Elisabeth Krankenhaus

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Essen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Frankfurt/M. : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Freiburg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Goch : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Gueglingen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Haag : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hamburg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Hamburg : Medical Care Center Prof. Mathey, Prof. Schofer GmbH

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Hamburg : Universitäres Herzzentrum Hamburg

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Hamburg : University Clinica Eppendorf

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Hamburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hannover : Medical School Hannover

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Hannover : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Heidelberg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Heidelberg : Uni.Klinikum Heidelberg

ABSORB EXTEND Clinical Investigation

Heidelberg : Abt. Herzchirugie, Universitätsklinikum Heidelberg

Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery

Heidelberg : Universitätsklinikum Heidelberg

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Heidelberg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Herford : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jena : Klinikum der Friedrich Schiller University

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Kelkheim : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kiel : Universitätsklinikum Schleswig-Holstein

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Kiel : Universitätsklinikum Schleswig-Holstein

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Koeln :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kuenzing : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Langen : Asklepios-Kliniken Langen

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Leipzg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Leipzig : Herzzentrum Universität Leipzig

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Leipzig : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lengerich : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lubeck : UniversitatsKlinikum Schleswig-Holstein

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Magdeburg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Magdeburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mainz : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Minden : Kardiologie /Intern. Intensivmedizin, Johannes Wesling Klinikum Minden

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Mönchengladbach : Kliniken Maria Hilf GmbH

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Muehldorf : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Muenchen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Münster : Universitätsklinikum Münster, Klinik für Kardiologie

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Potsdam : EvB Klinkum

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

Rhaunen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rostock : Universitat Rostok

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

Rostock : Medical University Rostock

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Rostock : University of Rostock

Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery

Schmiedeberg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sulzbach-Rosenberg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Trier : Krankenhaus Der Barmherzigen Brüder Trier

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Ulm : Universitätsklinikum Ulm

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Ulm : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Villingen-Schwenningen : Innere Medizin III Kardiologie, Kliniken Villingen

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Wallerfing : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Weyhe-Leeste : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Witten : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Agia Varvara, Athens : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Alexandroupolis : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Athens : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chalkida : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ioannina :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ioannina : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kallithea :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Magoula, Elefsina : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Patras : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Thessaloniki : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Voula / Athens : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hong Kong :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Hong Kong : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Shatin, New Territories : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Shatin, New Territories,SAR :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Berettyóújfalu : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Budapest :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Budapest : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Debrecen :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Komárom : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mosonmagyaróvár : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sátoraljaújhely : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Székesfehérvár : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Szikszó : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Szolnok : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ahmedabad : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bangalore : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cochin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jaipur : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lucknow, Utter Pradesh :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Mohali, Punjab :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Mysore : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New Delhi :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

New Delhi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Patiala : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pune : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Saket,Delhi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Vadodara : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Vijayawada : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Afula : HaEmek Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Ashkelon : Barzilai Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Beer Yahkov : Assaf Harofeh Medical Centre

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Haifa : Cardiovascular department, Carmel medical center

Monitoring and Characterization of Coronary Flow By Transthoracic Parametric Doppler (TPD) During Exercise Stress Test

Haifa : Rambam Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Haifa : Bnai Zion Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Holon :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Holon : Edith Wolfson Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jerusalem : Cardiology Department, Shaarey Zedek Hospital

Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG

Jerusalem : Shaare Zedek Medical Center

Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography

Jerusalem : Hadassah Ein-Kerem Medical Centre

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Jerusalem : Shaare Zedek Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kfar Saba :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kfar Saba : Meir Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kfar Saba : Dr. Silber Clinic

The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing

Nahariya : Western Galilee Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Natanya : Laniado Hospital

The Israeli MGuard Registry

Ofakim :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Rehovot : Kaplan Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Rehovot : Kaplan Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tel Aviv : Tel Aviv Souraski Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tel Hashomer : The Chaim Sheba Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tel viv : Theravitae Co.

ACPs Combined With CABG in Patients With CHF

Zafed : ZIV Medical Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Zrifin : Asaf Harofe Medical Center

The Israeli MGuard Registry

Ascoli Piceno : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Asti : Cardinal Massaia Hospital

COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent

Bergamo : Ospedali Riuniti di Bergamo

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Carpi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chieti : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cona (Ferrara) : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cotignola : Maria Cecilia Hospital

COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilm™ Coated Stent

Cuneo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Firenze : Azienda Ospedaliero-Universitaria Careggi

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Genova : Azienda Ospedaliera Universitaria San Martino

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Milano : Fondazione Centro S. Raffaele del Monte Tabor, Ospedale San Raffaele

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Milano : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Napoli : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Novara : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Palermo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Parma : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pisa :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Pisa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Roma :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Roma : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rome :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Sassari : Ospedale Civile SS Annunziata ASL 1

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Treviso : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Aichi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chiba : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Fukuoka : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hokkaido : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Itabashi-ku : Nihon University Itabashi Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Kagoshima : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kamakura-shi : Shonan Kamakura General Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Kanagawa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kitakyushu-shi : Kokura Memorial Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Kobe : Kobe University

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Kurume-shi : Kurume University Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Kyoto : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kyoto-shi : Kyoto University Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Minato-ku : The Cardiovascular Institute

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Nagano : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nagasaki : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nishinomiya : Hyogo Medical University

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Oita : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Osaka : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sakyo-ku : Kyoto University Hospital

ABSORB EXTEND Clinical Investigation

Shiga : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Shinagawa-ku : Showa University Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Shinjuku-ku : Department of Cardiology, Tokyo Women's Medical University

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Shizuoka : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Suita-shi : National Cerebral and Cardiovascular Center

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Tokyo : Teikyo University

ABSORB EXTEND Clinical Investigation

Tokyo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tokyo : Abbott Vascular Japan Co., Ltd.

XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan

Toyohashi : Toyohashi Heart Center

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Yokohama : Saiseikai Yokohama Eastern Hospital

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Yokohama-shi : Saiseikai Yokohamashi Tobu Hospital

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Yukuhashi : New Yukuhashi hospital

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

Busan : Inje university haeundae paik hospital

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Busan : Kosin university gospel hospital

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Busan : Pusan national university hospital

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Cheongju : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chunahn : Dankook University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Chungbuk : Chungbuk national university hospital

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Daegu : Daegu Catholic University Medical Center

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Daegu : Dong-A University Medical Center

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Dae-Gu : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Daejeon : Chungnam National University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Dongjak-Gu : Boramae Medical Center

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy

Gangnam-gu, Seoul : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

GangNeung : GangNeung Asan Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Gwangju : Chonnam National University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Gwangju : Chonnam National University Hospital

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Gwangju : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Gyeonggi-do : Dongguk University Medical Center

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Incheon : Inha University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Jeonju : Chonbuk National University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

jeonju-si, Jeollabuk-Do : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jinju : Gyeongsang National University Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Jongno-gu : Seoul National University Hospital

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy

Seogu : Dong-A Medical Center

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy

Seo-gu Busan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Seongnam : Bundang CHA Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Seongnam-si : Seoul National University Bundang Hospital

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy

Seongnam-si Gyeonggi-do : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Seoul :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Seoul : Gangnam Severance Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Seoul : Hanyang National University Medical Center

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Seoul : Asan Medical Center

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Seoul : Department of Medicine, Asan Medical Center University of Ulsan College of Medicine

Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)

Seoul : Asan Medical Center

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Seoul : Seoul National University Hospital

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Seoul : 29 Centers

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Seoul : Samsung Medical Center

Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy

Seoul : 8 Locations

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Seoul : SNU Boramae Medical Center

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Seoul : Seoul National University Hospital

Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Seoul : 26 Centers

The IRIS-Resolute Integrity (IRIS-Integrity)

Seoul : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Uijeongbu-si Kyonggi-do : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ulsan : Ulsan University Hospital

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Riga : Cardiology, Pauls Stradins Clinical University Hospital

Clinical Performance of the Pantera Lux DCB Versus the Orsiro DES in Patients With "-Limus" DES-ISR.

Kuala Lumpur :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kuala Lumpur : Institute Jantung Negara

ABSORB EXTEND Clinical Investigation

Kuantan, Pahang :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kubang Kerian :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kuching : Sarawak General Hospital

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)

Sarawak :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Durango : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Mexico : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

México D.F, : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Monterrey NL : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Alkmaar :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Amsterdam :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Amsterdam : Onze Lieve Vrouwe Gasthuis Ziekenhuis

DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting

Amsterdam : Academisch Medisch Centrum

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Amsterdam : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Amsterdam : Academic Medical Center - University of Amsterdam

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Beverwijk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Den Haag : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Doetinchem : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Eindhoven : Catharina ZH Eindhoven

ABSORB EXTEND Clinical Investigation

Eindhoven : Catharina Ziekenhuis

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Eindhoven : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Enschede : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Goes : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Harderwijk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hoofddorp : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Leeuwarden : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Maastricht :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Nieuwegein : St Antonius Hospital

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions

Nijmegen :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Rotterdam : Maasstadhospital

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Rotterdam : Maasstad Ziekenhuis

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Rotterdam : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rotterdam : Thorax Center - Erasmus MC

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Sittard-geleen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sneek : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

The Hague : Medisch Centrum Haaglanden

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Tiel : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tilburg : TweeSteden Ziekenhuis

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Utrecht :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Waalwijk :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Auckland : Mercy Angiography Unit

ABSORB EXTEND Clinical Investigation

Auckland : Ascot Angiography

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Auckland : Auckland City Hospital

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Auckland : Mercy Angiography Unit, Ltd. Mercy Hospital

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Auckland : North Shore Hospital

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Christchurch :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Christchurch : Christchurch

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Christchurch : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Dunedin : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Grafton, Auckland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hamilton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lower Hutt : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nelson : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Otahuhu : Middlemore Hospital

NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions

Otahuhu, Auckland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Palmerston North : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Takapuna, Auckland : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tauranga : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Timaru : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Whangarei : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bergen : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bodo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Moss : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oslo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Oslo : Oslo University Hospital

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Oslo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sandefjord :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Karachi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Korangi / Karachi : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lahore : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Multan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Rawalpindi Cantt : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Callao : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jesus Maria : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lima : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ermita, Manila : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Manila : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Quezon City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Juan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Belchatów : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bialystok :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Bialystok : Novartis Investigative Site

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Bielsko-Biala : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Bydgoszcz : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chrzanów : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Dabrowa Gornicza : Polsko-Amerykanskie Kliniki Serca III Oddzial Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

Dabrowa Górnicza : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Gdansk :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Gdynia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Katowice :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Katowice : SPZOZ, SPSK nr 7 Slaskiego Uniwersytetu Medycznego w Katowicach, Górnoslaskie Centrum Medyczne

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kedzierzyn Kozle : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kowanowko : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Krakow :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Krakow : Carint Scanmed Szpital Sw. Rafala

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

Krakow : Szpital Uniwersytecki w Krakowie, Samodzielna Pracownia Zakladu Hemodynamiki i Angiografii

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

Krakow : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kraków : Krakowski Szpital Specjalistyczny im. Jana Pawła II

Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000

Kraków : Szpital Uniwersytecki w Krakowie

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kraków : Novartis Investigative Site

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Lódz : Novartis Investigative Site

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Mielec : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Mielec : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Naleczow :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ostrow Wielkopolski : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Plonsk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Poznan :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Radom : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ruda Slaska : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Siemianowice Slaskie : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Skierniewice : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sopot :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Szczecin :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Torun : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tychy : American Heart of Poland S.A.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Tychy : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ustron : Polsko-Amerykanskie Kliniki Serca I Oddzial Kardiologiczno-Angiologiczny

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

Warsaw : Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego

Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000

Warszawa :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Warszawa : Centralny Szpital Kliniczny MSWiA w Warszawie Klinika Kardiologii Inwazyjnej

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

Warszawa : Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji w Warszawie

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Warszawa : Instytut Kardiologii

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Warszawa : Novartis Investigative Site

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Warszawa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wloclawek : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Wroclaw :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Wroclaw : 4th Wojskowy Szpital Kliniczny z Poliklinika, Klinika Kardiologii

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Wroclaw : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Guaynabo : San Patricio MEDFLIX (San Patricio MRI & CT Center)

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Rio Piedras : Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe

PRE-DETERMINE Cohort Study

San Juan : VA Caribbean Healthcare System

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Bucharest : University Hospital Bucharest

BIOFLOW-III Romania Satellite Registry

Bucharest : Cardiovascular Diseases Institute CC Iliescu

BIOFLOW-III Romania Satellite Registry

Bucharest : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cluj Napoca : County Emergency Hospital

BIOFLOW-III Romania Satellite Registry

Deva : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Galati : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Targu Mures : Country Hospital

BIOFLOW-III Romania Satellite Registry

Targu Mures : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Barnaul :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Barnaul : Altai Regional Cardiological Dispensary

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Chelyabinsk : Regional Clinical Hospital №3

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Ekaterinburg : Ural Institute of Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Ekaterinburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Ivanovo : Cardiological Dispensary

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kazan : Republic Clinical Hospital № 2

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kemerovo :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kemerovo : State Research Institute for Complex Issues of Cardiovascular Diseases

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI

Kemerovo : Research Institute for Complex Issues of Cardiovascular Diseases

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Kemerovo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kirovsk, Leningradskaya Region : Medical Center "Alliance"

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Krasnoyarsk : Regional Clinical Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Moscow : Municipal Hospital #15

Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease

Moscow : University Clinical Hospital #1

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow : National Research Center For Preventive Medicine

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow : City Clinical Hospital #15 named after O.M. Filatov

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow : "City Clinical Hospital # 23 n.a.

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow : City Clinical Hospital n.a. S.P.Botkin

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Moscow : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nizhni Novgorod : City Clinical Hospital #5

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Novosibirsk :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Novosibirsk : City Clinical Emergency Hospital # 2

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Novosibirsk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Penza : Penza Regional Clinical Hospital n.a. N.N. Burdenko

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Petrozavodsk :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ryazan :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Ryazan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

S.-Petresburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Saint Petersburg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Saint-Petersburg : Federal Center of Heart, Blood and Endocrinology n.a. V.A.Almazov

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

St Pertersburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St. Petersburg :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

St'Petersburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

St-Petersburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tomsk :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Tomsk : Scientific and Research Institution Of Cardiology

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Volgograd : Volgograd Regional Clinical Cardiological Center

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Yaroslavl :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Yekaterinburg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Singapore : National University Hospital

ABSORB EXTEND Clinical Investigation

Bratislava : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kosice : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Nitra : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bellville : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bloemfontein : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cape Town :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Johannesburg : Sunninghill Hospital

ABSORB EXTEND Clinical Investigation

Kempton Park : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kuils River : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lynnwood Ridge, Pretoria : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Olivedale : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Paarl : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Parktown : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Parktown West : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Parow : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Parow, Cape Town :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Pinelands : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pretoria :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Somerset West : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Soweto : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Umhlanga : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Alicante : Hospital General Universitario de Alicante

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Alicante : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Barcelona : Hospital Vall d´Hebrón

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Barcelona : Hospital Clinic I Provincial de Barcelona

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Barcelona : Hospital Trías i Pujol

The 001-DIOR Multicenter Registry

Barcelona : Hospital del Mar

The 001-DIOR Multicenter Registry

Barcelona : Hospital Sant Pau

The 001-DIOR Multicenter Registry

Granada : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Jerez de la Frontera : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

L´Hospitalet de Llobregat : Hospital Universitario de Bellvitge

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Madrid :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Madrid : La Paz

ABSORB EXTEND Clinical Investigation

Madrid : Hospital Universitario La Paz

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Madrid : Hospital Clínico San Carlos

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Madrid : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Malaga : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Marid : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oviedo : Hospital Central de Asturias

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Oviedo : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Pozuelo de Alarcón/Madrid : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Juan (Alicante) : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Sebastián : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

San Sebastián de los Reyes/Madrid : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Santander : Hospital Universitario Marques de Valdecilla

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Santander : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sevilla : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Sta Coloma de Gramanet (Barcelona) : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Valdemoro/Madrid : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Vigo : Complejo Hospitalario Universitario de Vigo, Meixoeiro Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Eksjö : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Falun : Falu lasarett

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Goteborg : Sahlgrenska Götheborg University Hospital

Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD.

Göteborg : Sahlgrenska Universitetsjukhuset

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Göteborg : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Karlstad : Centralsjukhuset i Karlstad

BIOFLOW-III Sweden Satellite Registry

Karlstad : Karlstad Central Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Linköping : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Lund : Lund University Hospital

ABSORB EXTEND Clinical Investigation

Lund : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Malmö : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oerebro : Kardiologiska Kliniken

BIOFLOW-III Sweden Satellite Registry

Örebro : Universitetssjukhuset Örebro

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Östersund : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Stockholm :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Stockholm : Danderyd University Hospital

BIOFLOW-III Sweden Satellite Registry

Stockholm : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Umeå : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Uppsala : Akademiska Sjukhuset i Uppsala

BIOFLOW-III Sweden Satellite Registry

Uppsala : Uppsala University Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Uppsala : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Västerås : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Västervik : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Aarau : Kantonsspital Aarau

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Basel : Universitätsklinik Basel

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Basel : University Hospital

The eSVS® Mesh Post-Marketing Trial

Bern : Department of Cardiology, Bern University Hospital

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Freiburg : HFR Freiburg

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Genève : Hôpitaux Universitaires de Genève

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Lausanne : Service de cardiologie CHUV

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Luzern : Luzerner Kantonsspital

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Meyrin : Hôpital de la Tour

A Randomized Clinical Evaluation of the BioFreedom™ Stent

St. Gallen : Kantonsspital St. Gallen

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Zurich : Unversitats Spital Zurich

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Zürich : Stadtspital Triemli

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Changhua : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

New Taipei City :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Niao-Sung Hsiang : Chang Gung Memorial Hospital

ABSORB EXTEND Clinical Investigation

Taichung : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Tainan : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Taipei :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Taipei : National Taiwan University Hospital

ABSORB EXTEND Clinical Investigation

Taipei : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Taipei City : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Bangkok : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chiangmai : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Donetsk : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kharkiv : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kharkiv City :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kiev :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kyiv :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Kyiv : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Kyiv City :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Lviv : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Odesa :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Odesa : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Odessa :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Vinnytsia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Zaporizhzhia : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Barnet : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Birmingham :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Brighton : Royal Sussex County Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Cambridge : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cardiff :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Chelsea : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chertsey : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Chichester : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Coatbridge : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cottingham : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Cumbernauld : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Glasgow : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hamilton : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Harrow : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Hertfordshire : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Liverpool :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Liverpool : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Liverpool : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

London :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

London : King's College

MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease

London : University College Hospital London NHS Foundation Trust

Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison

Manchester :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Middlesbrough : The James Cook University Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Motherwell : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Newcastle Upon Tyne : Freeman Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Newcastle-upon-Tyne : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Oldham :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Oxford :

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Paisley : GSK Investigational Site

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Surrey : Ashford and Saint Peter's Hospital NHS Trust

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

West Bromwich, West Midlands :

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

West Sussex : Saint Richards Hospital

Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

Myocardial Ischemia Clinical Trials

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

Wisconsin

Argentina

Australia

Austria

Belgium

Brazil

Bulgaria

Canada

Chile

China

Croatia

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Hong Kong

Hungary

India

Israel

Italy

Japan

Korea, Republic of

Latvia

Malaysia

Mexico

Netherlands

New Zealand

Norway

Pakistan